leisure time -WSS

leisure time

author：explore 2025-09-29 18:17:36 - browse：624

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How to save PrEP access — and even expand it
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

Wikipedia

WSS

AstraZeneca lung cancer study comes in below expectations

Affirmative action in medical school literally saved lives

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

A letter from the executive editor: The 2023 STATUS List

DIEP, the 'gold standard' of breast reconstruction, is under threat

Crowdfunding for unproven stem cell procedures spreads misinformation

entertainment

leisure time

Wikipedia

Medical records are filled with copy

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Activists slam private health insurers over coverage restrictions

Canadians with cystic fibrosis outlive Americans by a decade

Duchenne breakthrough therapy leaves behind pioneering families

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

After affirmative action ruling, medical educators look to 'holistic review'

Trump demands the U.S. pay no more for drugs than other countries … again

What does generative AI mean for health care? We asked experts

DIEP, the 'gold standard' of breast reconstruction, is under threat

hotspot

Peter Hotez and the public health issue of online harassment

Undocumented workers face uncertainty as immigration law takes effect in Florida

Peter Hotez and the public health issue of online harassment

Sports medicine is finally prioritizing gender equality

Alkermes shareholders re

The cancer drug shortage isn’t new — and neither are the solutions

leisure time

Wikipedia

focus

focus